SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026309
Filing Date
2021-05-11
Accepted
2021-05-11 08:16:24
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q phat-10q_20210331.htm 10-Q 1260158
2 EX-10.1 phat-ex101_241.htm EX-10.1 77627
3 EX-31.1 phat-ex311_9.htm EX-31.1 16934
4 EX-31.2 phat-ex312_6.htm EX-31.2 16948
5 EX-32.1 phat-ex321_10.htm EX-32.1 7394
6 EX-32.2 phat-ex322_7.htm EX-32.2 7387
  Complete submission text file 0001564590-21-026309.txt   5636502

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT phat-20210331.xml EX-101.INS 1003964
8 XBRL TAXONOMY EXTENSION SCHEMA phat-20210331.xsd EX-101.SCH 54011
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phat-20210331_cal.xml EX-101.CAL 42772
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phat-20210331_def.xml EX-101.DEF 202675
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20210331_lab.xml EX-101.LAB 446949
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20210331_pre.xml EX-101.PRE 336876
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 21909718
SIC: 2834 Pharmaceutical Preparations